Molecular mechanisms of foot-and-mouth disease virus targeting the host antiviral response

Frontiers in Cellular and Infection Microbiology

Volumn 7, Issue JUN, 2017, Pages

  Rodríguez Pulido, Miguel ^a   Sáiz, Margarita ^a  

^a CSIC   (Spain)

Author keywords

Foot and mouth disease virus; Innate immunity; Interferon; Viral evasion; Viral RNA detection; Virus host interaction

Indexed keywords

BETA INTERFERON; CYCLOOXYGENASE 2; DOUBLE STRANDED RNA; EHMT2 INHIBITOR; ENZYME INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON INDUCED HELICASE C DOMAIN CONTAINING PROTEIN 1; JANUS KINASE 1; KARYOPHERIN ALPHA 1; LGP2 PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; PROSTAGLANDIN E2; PROTEINASE; RANTES; RETINOIC ACID INDUCIBLE PROTEIN I; SINGLE STRANDED RNA; STAT1 PROTEIN; TBK1 PROTEIN; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; VIRAL PROTEIN; ANTIVIRUS AGENT; CYTOKINE; INTERFERON; PEPTIDE HYDROLASE; VIRUS RNA;

FOOT AND MOUTH DISEASE VIRUS; GENE EXPRESSION; HUMAN; IMMUNE EVASION; IMMUNOMODULATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MOLECULAR PATHOLOGY; NONHUMAN; PICORNAVIRIDAE; PROTEIN EXPRESSION; SHORT SURVEY; VIRUS GENOME; VIRUS REPLICATION; ANIMAL; DRUG EFFECTS; FOOT AND MOUTH DISEASE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PATHOGENICITY; SIGNAL TRANSDUCTION; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; CYTOKINES; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENOME, VIRAL; HOST-PATHOGEN INTERACTIONS; IMMUNE EVASION; IMMUNITY, INNATE; INTERFERONS; PEPTIDE HYDROLASES; RNA, VIRAL; SIGNAL TRANSDUCTION; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 85027575999     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2017.00252     Document Type: Short Survey

References (73)

1. Ao, D., Guo, H. C., Sun, S. Q., Sun, D. H., Fung, T. S., Wei, Y. Q., et al. (2015). Viroporin activity of the foot-and-mouth disease virus non-structural 2B protein. PLoS ONE 10:e0125828. doi: 10.1371/journal.pone.0125828
2. Barral, P. M., Sarkar, D., Fisher, P. B., and Racaniello, V. R. (2009). RIG-I is cleaved during picornavirus infection. Virology 391, 171–176. doi: 10.1016/j.virol.2009.06.045
3. Berke, I. C., Li, Y., and Modis, Y. (2013). Structural basis of innate immune recognition of viral RNA. Cell. Microbiol. 15, 386–394. doi: 10.1111/cmi.12061
4. Berryman, S., Brooks, E., Burman, A., Hawes, P., Roberts, R., Netherton, C., et al. (2012). Foot-and-mouth disease virus induces autophagosomes during cell entry via a class III phosphatidylinositol 3-kinase-independent pathway. J. Virol. 86, 12940–12953. doi: 10.1128/JVI.00846-12
5. Borrego, B., Blanco, E., Rodriguez Pulido, M., Mateos, F., Lorenzo, G., Cardillo, S., et al. (2017). Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine. Antiviral Res. 142, 30–36. doi: 10.1016/j.antiviral.2017.03.009
6. Bruns, A. M., and Horvath, C. M. (2014). Antiviral RNA recognition and assembly by RLR family innate immune sensors. Cytokine Growth Factor Rev. 25, 507–512. doi: 10.1016/j.cytogfr.2014.07.006
7. Bruns, A. M., Leser, G. P., Lamb, R. A., and Horvath, C. M. (2014). The innate immune sensor LGP2 activates antiviral signaling by regulating MDA5-RNA interaction and filament assembly. Mol. Cell 55, 771–781. doi: 10.1016/j.molcel.2014.07.003
8. Bruns, A. M., Pollpeter, D., Hadizadeh, N., Myong, S., Marko, J. F., and Horvath, C. M. (2013). ATP hydrolysis enhances RNA recognition and antiviral signal transduction by the innate immune sensor, laboratory of genetics and physiology 2 (LGP2). J. Biol. Chem. 288, 938–946. doi: 10.1074/jbc.M112.424416
9. Chinsangaram, J., Koster, M., and Grubman, M. J. (2001). Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J. Virol. 75, 5498–5503. doi: 10.1128/JVI.75.12.5498-5503.2001
10. Cuevas, R. A., Ghosh, A., Wallerath, C., Hornung, V., Coyne, C. B., and Sarkar, S. N. (2016). MOV10 provides antiviral activity against RNA viruses by enhancing RIG-I-MAVS-independent IFN induction. J. Immunol. 196, 3877–3886. doi: 10.4049/jimmunol.1501359
11. de Los Santos, T., de Avila Botton, S., Weiblen, R., and Grubman, M. J. (2006). The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J. Virol. 80, 1906–1914. doi: 10.1128/JVI.80.4.1906-1914.2006
12. de Los Santos, T., Diaz-San Segundo, F., and Grubman, M. J. (2007). Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J. Virol. 81, 12803–12815. doi: 10.1128/JVI.01467-07
13. de Los Santos, T., Segundo, F. D., Zhu, J., Koster, M., Dias, C. C., and Grubman, M. J. (2009). A conserved domain in the leader proteinase of foot-and-mouth disease virus is required for proper subcellular localization and function. J. Virol. 83, 1800–1810. doi: 10.1128/JVI.02112-08
14. Deddouche, S., Goubau, D., Rehwinkel, J., Chakravarty, P., Begum, S., Maillard, P. V., et al. (2014). Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells. Elife 3:e01535. doi: 10.7554/eLife.01535
15. Devaney, M. A., Vakharia, V. N., Lloyd, R. E., Ehrenfeld, E., and Grubman, M. J. (1988). Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J. Virol. 62, 4407–4409.
16. Diaz-San Segundo, F., Moraes, M. P., de Los Santos, T., Dias, C. C., and Grubman, M. J. (2010). Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression. J. Virol. 84, 2063–2077. doi: 10.1128/JVI.01874-09
17. Dotzauer, A., and Kraemer, L. (2012). Innate and adaptive immune responses against picornaviruses and their counteractions: an overview. World J. Virol. 1, 91–107. doi: 10.5501/wjv.v1.i3.91
18. Du, Y., Bi, J., Liu, J., Liu, X., Wu, X., Jiang, P., et al. (2014). 3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation. J. Virol. 88, 4908–4920. doi: 10.1128/JVI.03668-13
19. Falk, M. M., Grigera, P. R., Bergmann, I. E., Zibert, A., Multhaup, G., and Beck, E. (1990). Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. J. Virol. 64, 748–756.
20. Fan, X., Han, S., Yan, D., Gao, Y., Wei, Y., Liu, X., et al. (2017). Foot-and-mouth disease virus infection suppresses autophagy and NF-small ka, CyrillicB antiviral responses via degradation of ATG5-ATG12 by 3Cpro. Cell Death Dis. 8, e2561. doi: 10.1038/cddis.2016.489
21. Feng, Q., Hato, S. V., Langereis, M. A., Zoll, J., Virgen-Slane, R., Peisley, A., et al. (2012). MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep. 2, 1187–1196. doi: 10.1016/j.celrep.2012.10.005
22. Feng, Q., Langereis, M. A., and van Kuppeveld, F. J. (2014). Induction and suppression of innate antiviral responses by picornaviruses. Cytokine Growth Factor Rev. 25, 577–585. doi: 10.1016/j.cytogfr.2014.07.003
23. Fensterl, V., Chattopadhyay, S., and Sen, G. C. (2015). No love lost between viruses and interferons. Annu. Rev. Virol. 2, 549–572. doi: 10.1146/annurev-virology-100114-055249
24. Golde, W. T., Nfon, C. K., and Toka, F. N. (2008). Immune evasion during foot-and-mouth disease virus infection of swine. Immunol. Rev. 225, 85–95. doi: 10.1111/j.1600-065X.2008.00672.x
25. Gonzalez-Magaldi, M., Martin-Acebes, M. A., Kremer, L., and Sobrino, F. (2014). Membrane topology and cellular dynamics of foot-and-mouth disease virus 3A protein. PLoS ONE 9:e106685. doi: 10.1371/journal.pone.0106685
26. Grubman, M. J., Moraes, M. P., Diaz-San Segundo, F., Pena, L., and de los Santos, T. (2008). Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen. FEMS Immunol. Med. Microbiol. 53, 8–17. doi: 10.1111/j.1574-695X.2008.00409.x
27. Guzylack-Piriou, L., Bergamin, F., Gerber, M., McCullough, K. C., and Summerfield, A. (2006). Plasmacytoid dendritic cell activation by foot-and-mouth disease virus requires immune complexes. Eur. J. Immunol. 36, 1674–1683. doi: 10.1002/eji.200635866
28. Ho, M. Y., Hung, S. W., Liang, C. M., and Liang, S. M. (2014). Recombinant viral capsid protein VP1 suppresses lung cancer metastasis by inhibiting COX-2/PGE2 and MIG-7. Oncotarget 5, 3931–3943. doi: 10.18632/oncotarget.2040
29. Huang, L., Liu, Q., Zhang, L., Zhang, Q., Hu, L., Li, C., et al. (2015). Encephalomyocarditis virus 3C protease relieves TANK inhibitory effect on TRAF6-mediated NF-kappaB signaling through cleavage of TANK. J. Biol. Chem. 290, 27618–27632. doi: 10.1074/jbc.M115.660761
30. Husser, L., Alves, M. P., Ruggli, N., and Summerfield, A. (2011). Identification of the role of RIG-I, MDA-5 and TLR3 in sensing RNA viruses in porcine epithelial cells using lentivirus-driven RNA interference. Virus Res. 159, 9–16. doi: 10.1016/j.virusres.2011.04.005
31. Knight-Jones, T. J., Robinson, L., Charleston, B., Rodriguez, L. L., Gay, C. G., Sumption, K. J., et al. (2016). Global foot-and-mouth disease research update and gap analysis: 2 - epidemiology, wildlife and economics. Transbound Emerg. Dis. 63(Suppl. 1), 14–29. doi: 10.1111/tbed.12522
32. Lannes, N., Python, S., and Summerfield, A. (2012). Interplay of foot-and-mouth disease virus, antibodies and plasmacytoid dendritic cells: virus opsonization under non-neutralizing conditions results in enhanced interferon-alpha responses. Vet. Res. 43:64. doi: 10.1186/1297-9716-43-64
33. Lei, X., Sun, Z., Liu, X., Jin, Q., He, B., and Wang, J. (2011). Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 85, 8811–8818. doi: 10.1128/JVI.00447-11
34. Lester, S. N., and Li, K. (2014). Toll-like receptors in antiviral innate immunity. J. Mol. Biol. 426, 1246–1264. doi: 10.1016/j.jmb.2013.11.024
35. Li, D., Lei, C., Xu, Z., Yang, F., Liu, H., Zhu, Z., et al. (2016a). Foot-and-mouth disease virus non-structural protein 3A inhibits the interferon-beta signaling pathway. Sci. Rep. 6:21888. doi: 10.1038/srep21888
36. Li, D., Wei, J., Yang, F., Liu, H. N., Zhu, Z. X., Cao, W. J., et al. (2016b). Foot-and-mouth disease virus structural protein VP3 degrades Janus kinase 1 to inhibit IFN-gamma signal transduction pathways. Cell Cycle 15, 850–860. doi: 10.1080/15384101.2016.1151584
37. Li, D., Yang, W., Yang, F., Liu, H., Zhu, Z., Lian, K., et al. (2016c). The VP3 structural protein of foot-and-mouth disease virus inhibits the IFN-beta signaling pathway. FASEB J. 30, 1757–1766. doi: 10.1096/fj.15-281410
38. Li, W., Ross-Smith, N., Proud, C. G., and Belsham, G. J. (2001). Cleavage of translation initiation factor 4AI (eIF4AI) but not eIF4AII by foot-and-mouth disease virus 3C protease: identification of the eIF4AI cleavage site. FEBS Lett. 507, 1–5. doi: 10.1016/S0014-5793(01)02885-X
39. Li, X., Wang, J., Liu, J., Li, Z., Wang, Y., Xue, Y., et al. (2013). Engagement of soluble resistance-related calcium binding protein (sorcin) with foot-and-mouth disease virus (FMDV) VP1 inhibits type I interferon response in cells. Vet. Microbiol. 166, 35–46. doi: 10.1016/j.vetmic.2013.04.028
40. Liu, Y., Olagnier, D., and Lin, R. (2016). Host and viral modulation of RIG-I-mediated antiviral immunity. Front. Immunol. 7:662. doi: 10.3389/fimmu.2016.00662
41. Longatti, A. (2015). The dual role of exosomes in hepatitis A and C virus transmission and viral immune activation. Viruses 7, 6707–6715. doi: 10.3390/v7122967
42. Lund, J. M., Alexopoulou, L., Sato, A., Karow, M., Adams, N. C., Gale, N. W., et al. (2004). Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. U.S.A. 101, 5598–5603. doi: 10.1073/pnas.0400937101
43. Medina, G. N., Knudsen, G. M., Greninger, A. L., Kloc, A., Diaz-San Segundo, F., Rieder, E., et al. (2017). Interaction between FMDV Lpro and transcription factor ADNP is required for optimal viral replication. Virology 505, 12–22. doi: 10.1016/j.virol.2017.02.010
44. Medina, M., Domingo, E., Brangwyn, J. K., and Belsham, G. J. (1993). The two species of the foot-and-mouth disease virus leader protein, expressed individually, exhibit the same activities. Virology 194, 355–359. doi: 10.1006/viro.1993.1267
45. Moffat, K., Knox, C., Howell, G., Clark, S. J., Yang, H., Belsham, G. J., et al. (2007). Inhibition of the secretory pathway by foot-and-mouth disease virus 2BC protein is reproduced by coexpression of 2B with 2C, and the site of inhibition is determined by the subcellular location of 2C. J. Virol. 81, 1129–1139. doi: 10.1128/JVI.00393-06
46. Mukherjee, A., Morosky, S. A., Delorme-Axford, E., Dybdahl-Sissoko, N., Oberste, M. S., Wang, T., et al. (2011). The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 7:e1001311. doi: 10.1371/journal.ppat.1001311
47. O'Donnell, V., Pacheco, J. M., LaRocco, M., Burrage, T., Jackson, W., Rodriguez, L. L., et al. (2011). Foot-and-mouth disease virus utilizes an autophagic pathway during viral replication. Virology 410, 142–150. doi: 10.1016/j.virol.2010.10.042
48. Papon, L., Oteiza, A., Imaizumi, T., Kato, H., Brocchi, E., Lawson, T. G., et al. (2009). The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology 393, 311–318. doi: 10.1016/j.virol.2009.08.009
49. Porter, F. W., Bochkov, Y. A., Albee, A. J., Wiese, C., and Palmenberg, A. C. (2006). A picornavirus protein interacts with Ran-GTPase and disrupts nucleocytoplasmic transport. Proc. Natl. Acad. Sci. U.S.A. 103, 12417–12422. doi: 10.1073/pnas.0605375103
50. Qu, L., Feng, Z., Yamane, D., Liang, Y., Lanford, R. E., Li, K., et al. (2011). Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD. PLoS Pathog. 7:e1002169. doi: 10.1371/journal.ppat.1002169
51. Robinson, L., Knight-Jones, T. J., Charleston, B., Rodriguez, L. L., Gay, C. G., Sumption, K. J., et al. (2016a). Global foot-and-mouth disease research update and gap analysis: 3 - vaccines. Transbound Emerg. Dis. 63(Suppl 1), 30–41. doi: 10.1111/tbed.12521
52. Robinson, L., Knight-Jones, T. J., Charleston, B., Rodriguez, L. L., Gay, C. G., Sumption, K. J., et al. (2016b). Global foot-and-mouth disease research update and gap analysis: 5 - biotherapeutics and disinfectants. Transbound Emerg. Dis. 63(Suppl. 1), 49–55. doi: 10.1111/tbed.12519
53. Rodriguez-Pulido, M., Sobrino, F., Borrego, B., and Saiz, M. (2011). Inoculation of newborn mice with non-coding regions of foot-and-mouth disease virus RNA can induce a rapid, solid and wide-range protection against viral infection. Antiviral Res. 92, 500–504. doi: 10.1016/j.antiviral.2011.10.005
54. Saiz, M., Nunez, J. I., Jimenez-Clavero, M. A., Baranowski, E., and Sobrino, F. (2002). Foot-and-mouth disease virus: biology and prospects for disease control. Microbes Infect. 4, 1183–1192. doi: 10.1016/S1286-4579(02)01644-1
55. Sangar, D. V., Newton, S. E., Rowlands, D. J., and Clarke, B. E. (1987). All foot and mouth disease virus serotypes initiate protein synthesis at two separate AUGs. Nucleic Acids Res. 15, 3305–3315.
56. Schlee, M. (2013). Master sensors of pathogenic RNA - RIG-I like receptors. Immunobiology 218, 1322–1335. doi: 10.1016/j.imbio.2013.06.007
57. Schulz, K. S., and Mossman, K. L. (2016). Viral evasion strategies in type I IFN signaling - a summary of recent developments. Front. Immunol. 7:498. doi: 10.3389/fimmu.2016.00498
58. Singh, N., Ramijrez-Carvajal, L., de Los Santos, T., Golding, M. C., and Long, C. R. (2016). Inhibition of EHMT2 induces a robust antiviral response against foot-and-mouth disease and vesicular stomatitis virus infections in bovine cells. J. Interferon Cytokine Res. 36, 37–47. doi: 10.1089/jir.2015.0006
59. ∗ protein through direct inhibition of RNase L. PLoS Pathog. 9:e1003474. doi: 10.1371/journal.ppat.1003474
60. Summerfield, A., Guzylack-Piriou, L., Harwood, L., and McCullough, K. C. (2009). Innate immune responses against foot-and-mouth disease virus: current understanding and future directions. Vet. Immunol. Immunopathol. 128, 205–210. doi: 10.1016/j.vetimm.2008.10.296
61. Toka, F. N., and Golde, W. T. (2013). Cell mediated innate responses of cattle and swine are diverse during foot-and-mouth disease virus (FMDV) infection: a unique landscape of innate immunity. Immunol. Lett. 152, 135–143. doi: 10.1016/j.imlet.2013.05.007
62. Uchikawa, E., Lethier, M., Malet, H., Brunel, J., Gerlier, D., and Cusack, S. (2016). Structural analysis of dsRNA Binding to anti-viral pattern recognition receptors LGP2 and MDA5. Mol. Cell 62, 586–602. doi: 10.1016/j.molcel.2016.04.021
63. Uze, G., and Monneron, D. (2007). IL-28 and IL-29: newcomers to the interferon family. Biochimie 89, 729–734. doi: 10.1016/j.biochi.2007.01.008
64. Wang, D., Fang, L., Bi, J., Chen, Q., Cao, L., Luo, R., et al. (2011a). Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced RANTES transcription in PK-15 cells. Virus Genes 42, 388–393. doi: 10.1007/s11262-011-0590-z
65. Wang, D., Fang, L., Li, K., Zhong, H., Fan, J., Ouyang, C., et al. (2012). Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling. J. Virol. 86, 9311–9322. doi: 10.1128/JVI.00722-12
66. Wang, D., Fang, L., Li, P., Sun, L., Fan, J., Zhang, Q., et al. (2011b). The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. J. Virol. 85, 3758–3766. doi: 10.1128/JVI.02589-10
67. Wang, D., Fang, L., Liu, L., Zhong, H., Chen, Q., Luo, R., et al. (2011c). Foot-and-mouth disease virus (FMDV) leader proteinase negatively regulates the porcine interferon-lambda1 pathway. Mol. Immunol. 49, 407–412. doi: 10.1016/j.molimm.2011.09.009
68. Wang, D., Fang, L., Luo, R., Ye, R., Fang, Y., Xie, L., et al. (2010). Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced type I interferon transcription by decreasing interferon regulatory factor 3/7 in protein levels. Biochem. Biophys. Res. Commun. 399, 72–78. doi: 10.1016/j.bbrc.2010.07.044
69. Yang, Y., Liang, Y., Qu, L., Chen, Z., Yi, M., Li, K., et al. (2007). Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc. Natl. Acad. Sci. USA. 104, 7253–7258. doi: 10.1073/pnas.0611506104
70. Zhu, J., Weiss, M., Grubman, M. J., and de los Santos, T. (2010). Differential gene expression in bovine cells infected with wild type and leaderless foot-and-mouth disease virus. Virology 404, 32–40. doi: 10.1016/j.virol.2010. 04.021
71. Zhu, Z., Li, C., Du, X., Wang, G., Cao, W., Yang, F., et al. (2017). Foot-and-mouth disease virus infection inhibits LGP2 protein expression to exaggerate inflammatory response and promote viral replication. Cell Death Dis. 8:e2747. doi: 10.1038/cddis.2017.170
72. Zhu, Z., Wang, G., Yang, F., Cao, W., Mao, R., Du, X., et al. (2016). Foot-and-mouth disease virus viroporin 2B antagonizes RIG-I-mediated antiviral effects by inhibition of its protein expression. J. Virol. 90, 11106–11121. doi: 10.1128/JVI.01310-16
73. Zinzula, L., and Tramontano, E. (2013). Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: hide, mask, hit. Antiviral Res. 100, 615–635. doi: 10.1016/j.antiviral.2013.10.002